Barely Significant
← all excerpts

SEOM-GEMCAD-TTD clinical guidelines for anal cancer (2025).

Clin Transl Oncol · 2026 · PMC13009044 · PMID 41653360

Europe PMCDOI
1
hedged sentence
0.0273
closest p · 0.5× alpha
0.0273
boldest claim

The sentences

a strong trendp = 0.0273actually significant
Moreover, there was a strong trend toward improved OS in favor of the retifanlimab arm (median OS: 29.2 months vs. 23.0 months; HR 0.70; 95% CI 0.49–1.01; p = 0.0273), although survival data were immature at data cutoff [ 43 ].

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.